Net income
-106 million USD
2025-07-01 – 2026-06-30
Fundies. English
Fractyl Health, Inc.
EDGAR24 filing records in this dataset, filed from 2016-02-19 to 2026-10-22. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 47.1 million USD Source
Exact value
47100000 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 159 million shares Source
Exact value
158648963 shares
Reported share-count change
217.82% · 109 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Operating cash flow
-82.4 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Operating cash flow: -68992000 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -46278000 USD · 2025-01-01 – 2025-06-30 Source
- Operating cash flow: -90328000 USD · 2025-01-01 – 2025-12-31 Source
- Operating cash flow: -68992000 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -22477000 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: -38378000 USD · 2026-01-01 – 2026-06-30 Source
- Operating cash flow: -22477000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure
557 thousand USD
2025-01-01 – 2025-12-31
Exact inputs and evidence
- Capital expenditure: 448000 USD · 2025-01-01 – 2025-03-31 Source
- Capital expenditure: 546000 USD · 2025-01-01 – 2025-06-30 Source
- Capital expenditure: 448000 USD · 2025-01-01 – 2025-03-31 Source
- Capital expenditure: 554000 USD · 2025-01-01 – 2025-09-30 Source
- Capital expenditure: 546000 USD · 2025-01-01 – 2025-06-30 Source
- Capital expenditure: 557000 USD · 2025-01-01 – 2025-12-31 Source
- Capital expenditure: 554000 USD · 2025-01-01 – 2025-09-30 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-22.
Financial data available through: 2025-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 3 of 11 periods available· newest 2025-12-31
- Net income: 3 of 11 periods available· newest 2025-12-31
- Operating cash flow: 3 of 11 periods available· newest 2025-12-31
- Capital expenditure: 3 of 11 periods available· newest 2025-12-31
- Total assets: 3 of 11 periods available· newest 2025-12-31
- Total liabilities: 3 of 11 periods available· newest 2025-12-31
- Current assets: 3 of 11 periods available· newest 2025-12-31
- Current liabilities: 3 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 3 of 11 periods available· newest 2025-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 3 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
−USD 72.26 millionPrior period
−USD 68.69 million
–
Current period
−USD 140.95 million
–
Exact inputs and evidence
-140954000 − -68694000 = -72260000 USD
-68694000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-140954000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 24.81 millionPrior period
−USD 65.52 million
–
Current period
−USD 90.33 million
–
Exact inputs and evidence
-90328000 − -65521000 = -24807000 USD
-65521000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-90328000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-68.4%Prior period
USD 1.77 million
–
Current period
USD 557,000
–
Exact inputs and evidence
557000 − 1765000 = -1208000 USD
1765000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source557000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | −USD 77.09 million Exact valueExact value: -77091000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 42.82 million Exact valueExact value: -42823000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 359,000 Exact valueExact value: 359000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 43.18 million Calculation and evidence-42823000 − 359000 USD Exact free cash flow: -43182000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 68.69 million Exact valueExact value: -68694000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 65.52 million Exact valueExact value: -65521000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.77 million Exact valueExact value: 1765000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 67.29 million Calculation and evidence-65521000 − 1765000 USD Exact free cash flow: -67286000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 140.95 million Exact valueExact value: -140954000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 90.33 million Exact valueExact value: -90328000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 557,000 Exact valueExact value: 557000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 90.89 million Calculation and evidence-90328000 − 557000 USD Exact free cash flow: -90885000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
24 filings · 715 latest values · 715 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001572616, 1572616, GUTS, edgar:1572616
Also known as FRACTYL HEALTH, INC., Fractyl Health, Inc., Fractyl Laboratories Inc.